Cargando...
Clinical Options in Relapsed or Refractory Hodgkin Lymphoma: An Updated Review
Hodgkin lymphoma (HL) is a potentially curable lymphoma, and modern therapy is expected to successfully cure more than 80% of the patients. Second-line salvage high-dose chemotherapy and autologous stem cell transplantation (auto-SCT) have an established role in the management of refractory and rela...
Gardado en:
| Publicado en: | J Immunol Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4695673/ https://ncbi.nlm.nih.gov/pubmed/26788526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/968212 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|